Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
top of page
Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
Jan 3, 2019
Alpha radiation startup eliminates 70% of cancerous tumors
#CancerBuster Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid...
Nov 7, 2018
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and
Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Sep 5, 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Aug 22, 2018
Israeli Oncology Company Alpha Tau is Raising Funds
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars. Israeli oncology company Alpha Tau...
Aug 22, 2018
Israeli Medical Startups Beat a Path to Aging Japan
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
bottom of page